CASTLEMAN HASTALIĞI

Year 2005, Volume: 18 Issue: 2, 81 - 83, 29.06.2015

Aslı Akgül Bedrettin Yıldızeli Mustafa Yüksel

Abstract

Castleman hastalığı ye da dev lenf nodülü hiperplazisi, genellikle viseral mediyasteni tutan nadir bir hastalıktır. Yazımızda hiler lenf hiperplazisi ile prezante olan bir Castleman olgusu sunmaktayız.

Keywords

Castleman, Akciğer, Mediyastinel tümör, Cerrahi

References

• 1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822-830.
• 2. Irsutti M, Paul JL, Selves J, Railhac JJ. Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus. Eur Radiol 1999;9:1219- 1221.
• 3. Poyanly A, Genç FA, Sencer S, Yanar H, Kapran Y. Cervical Castleman’s disease: imaging findings. A case report. Eur Radiol 2000;10:1190-1192.
• 4. Seirafi PA, Ferguson E, Edwards FH. Thoracoscopic resection of Castleman Disease. Chest 2003;123:280- 282.
• 5. Rena O, Casadio C, Maggi G. Castleman’s disease: unusual inthrathoracic localization. Eur J Cardiothorac Surg 2001;19:519-521.
• 6. Ferrozzi F, Tognini G, Spaggiari E, Pavone P. Focal Castleman disease of the lung MRI findings. J Clin Imaging 2001;25:400-402.
• 7. Johkoh T, Müller NL, Ichikado K, et al. Intrathoracic multicentric Castleman’s disease: CT findings in 12 patients. Radiology 1998;209:47-81
• 8. Spedini C, Lombardi C, Lanzani G, Di Fabio D, Chiodera PL. Castleman’s Disease presenting as an asymptomatic solitary pulmonary nodule. Monaldi Arch Chest Dis 1995;50:363-365.
• 9. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000;95:56-61
• 10. Parez N, Bader-Meunier B, Roy CC, et al. Pediatric Castleman Disease: Report of seven cases and review of literature. Eur J Pediatr 1999;158:631-663.
• 11. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi’s sarcoma-associated herpes virus-like DNA sequences in multicentric Castleman’s disease. Blood 1995;86:1276- 1280.
• 12. Wilkinson S, Forrester-Wood CF. Surgical resection of a solitary plasmacytoma originating in a rib of a patient with Castleman’s Disease. Ann Thorac Surg 2003;75:1018-1019.
• 13. Reynolds SP, Gibbs AR, Weeks R, Adams H, Davies BH. Massive pleural effusion: an unusual presentation of Castleman’s disease. Eur Respir J 1992;5:1150-1153.
• 14. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001;92:670-676.
• 15. Repetto L, Jaiprakash MP, Selby PJ, Gusterson BA, Williams HJ, McElwain TJ. Aggressive angiofollicular lymph node hyperplasia (Castleman’s disease) treated with high dose melphalan and autologous bone marrow transplantation. Hematol Oncol 1986;4:213-217.
• 16. Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman’s disease by monoclonal anti-interleukin-6 antibody. N Engl Med 1994;330:602-605.
• 17. Barrie JR, English JC, Muller N. Castleman’s disease of the lung: radiographic, high resolution CT and pathologic findings. AJR, Am J Roentgenol 1996;166:1055-1056.